APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antihelminthics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Antihelminthics Market Outlook and Growth Opportunities 2026

19 December 2025191 pages

Choose your research edition.

Industry ResearchAntihelminthics Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Antihelminthics Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Antihelminthics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antihelminthics Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Antihelminthics Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Antihelminthics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antihelminthics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antihelminthics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antihelminthics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antihelminthics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antihelminthics market include Abbott, Sanofi, Sanofi, Johnson & Johnson, Novartis, Pfizer, GlaxoSmithKline, Bayer and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antihelminthics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antihelminthics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antihelminthics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antihelminthics market size, projected growth trends, production technologies, key applications, and end-use industries.

Antihelminthics Segment by Company

Abbott

Sanofi

Sanofi

Johnson & Johnson

Novartis

Pfizer

GlaxoSmithKline

Bayer

AstraZeneca

ZEISS International

Merck & Co.

Mentis Pharma

Astellas Pharma

ALLERGAN

Antihelminthics Segment by Type

Salicylanilides

Benzimidazoles

Praziquantel

Abamectin

Other

Antihelminthics Segment by Application

Ascariasis

Giardiasis

Fasciolasis

Filariasis

Angiostrongylosis

Schistosomiasis

Other

Antihelminthics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Antihelminthics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Antihelminthics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antihelminthics significant trends, drivers, influence factors in global and regions.

6. To analyze Antihelminthics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antihelminthics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antihelminthics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antihelminthics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antihelminthics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antihelminthics industry.

Chapter 3: Detailed analysis of Antihelminthics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Antihelminthics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Antihelminthics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antihelminthics Industry Trends Table 2. Antihelminthics Industry Drivers Table 3. Antihelminthics Industry Opportunities and Challenges Table 4. Antihelminthics Industry Restraints Table 5. Global Antihelminthics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antihelminthics Revenue Share by Company (2021-2026) Table 7. Global Antihelminthics Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Antihelminthics Sales Volume Share by Company (2021-2026) Table 9. Global Antihelminthics Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Antihelminthics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Antihelminthics Key Company Manufacturing Base & Headquarters Table 12. Global Antihelminthics Company, Product Type & Application Table 13. Global Antihelminthics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Antihelminthics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Salicylanilides Table 18. Significant Companies of Benzimidazoles Table 19. Significant Companies of Praziquantel Table 20. Significant Companies of Abamectin Table 21. Significant Companies of Other Table 22. Global Antihelminthics Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Antihelminthics Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Antihelminthics Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Antihelminthics Sales Volume Share by Type (2021-2026) Table 26. Global Antihelminthics Sales Volume Share by Type (2027-2032) Table 27. Global Antihelminthics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Antihelminthics Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Antihelminthics Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Antihelminthics Sales Value Share by Type (2021-2026) Table 31. Global Antihelminthics Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Ascariasis Table 33. Significant Companies of Giardiasis Table 34. Significant Companies of Fasciolasis Table 35. Significant Companies of Filariasis Table 36. Significant Companies of Angiostrongylosis Table 37. Significant Companies of Schistosomiasis Table 38. Significant Companies of Other Table 39. Global Antihelminthics Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Antihelminthics Sales Volume by Application (2021-2026) & (K Units) Table 41. Global Antihelminthics Sales Volume by Application (2027-2032) & (K Units) Table 42. Global Antihelminthics Sales Volume Share by Application (2021-2026) Table 43. Global Antihelminthics Sales Volume Share by Application (2027-2032) Table 44. Global Antihelminthics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Antihelminthics Sales Value by Application (2021-2026) & (US$ Million) Table 46. Global Antihelminthics Sales Value by Application (2027-2032) & (US$ Million) Table 47. Global Antihelminthics Sales Value Share by Application (2021-2026) Table 48. Global Antihelminthics Sales Value Share by Application (2027-2032) Table 49. Global Antihelminthics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 50. Global Antihelminthics Sales by Region (2021-2026) & (K Units) Table 51. Global Antihelminthics Sales Market Share by Region (2021-2026) Table 52. Global Antihelminthics Sales by Region (2027-2032) & (K Units) Table 53. Global Antihelminthics Sales Market Share by Region (2027-2032) Table 54. Global Antihelminthics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Antihelminthics Sales Value by Region (2021-2026) & (US$ Million) Table 56. Global Antihelminthics Sales Value Share by Region (2021-2026) Table 57. Global Antihelminthics Sales Value by Region (2027-2032) & (US$ Million) Table 58. Global Antihelminthics Sales Value Share by Region (2027-2032) Table 59. Global Antihelminthics Market Average Price (US$/Unit) by Region (2021-2026) Table 60. Global Antihelminthics Market Average Price (US$/Unit) by Region (2027-2032) Table 61. Global Antihelminthics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 62. Global Antihelminthics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Antihelminthics Sales by Country (2021-2026) & (K Units) Table 64. Global Antihelminthics Sales Market Share by Country (2021-2026) Table 65. Global Antihelminthics Sales by Country (2027-2032) & (K Units) Table 66. Global Antihelminthics Sales Market Share by Country (2027-2032) Table 67. Global Antihelminthics Sales Value by Country (2021-2026) & (US$ Million) Table 68. Global Antihelminthics Sales Value Market Share by Country (2021-2026) Table 69. Global Antihelminthics Sales Value by Country (2027-2032) & (US$ Million) Table 70. Global Antihelminthics Sales Value Market Share by Country (2027-2032) Table 71. Abbott Company Information Table 72. Abbott Business Overview Table 73. Abbott Antihelminthics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Abbott Antihelminthics Product Portfolio Table 75. Abbott Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Antihelminthics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sanofi Antihelminthics Product Portfolio Table 80. Sanofi Recent Development Table 81. Sanofi Company Information Table 82. Sanofi Business Overview Table 83. Sanofi Antihelminthics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sanofi Antihelminthics Product Portfolio Table 85. Sanofi Recent Development Table 86. Johnson & Johnson Company Information Table 87. Johnson & Johnson Business Overview Table 88. Johnson & Johnson Antihelminthics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Johnson & Johnson Antihelminthics Product Portfolio Table 90. Johnson & Johnson Recent Development Table 91. Novartis Company Information Table 92. Novartis Business Overview Table 93. Novartis Antihelminthics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Novartis Antihelminthics Product Portfolio Table 95. Novartis Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Antihelminthics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Pfizer Antihelminthics Product Portfolio Table 100. Pfizer Recent Development Table 101. GlaxoSmithKline Company Information Table 102. GlaxoSmithKline Business Overview Table 103. GlaxoSmithKline Antihelminthics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. GlaxoSmithKline Antihelminthics Product Portfolio Table 105. GlaxoSmithKline Recent Development Table 106. Bayer Company Information Table 107. Bayer Business Overview Table 108. Bayer Antihelminthics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Bayer Antihelminthics Product Portfolio Table 110. Bayer Recent Development Table 111. AstraZeneca Company Information Table 112. AstraZeneca Business Overview Table 113. AstraZeneca Antihelminthics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. AstraZeneca Antihelminthics Product Portfolio Table 115. AstraZeneca Recent Development Table 116. ZEISS International Company Information Table 117. ZEISS International Business Overview Table 118. ZEISS International Antihelminthics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. ZEISS International Antihelminthics Product Portfolio Table 120. ZEISS International Recent Development Table 121. Merck & Co. Company Information Table 122. Merck & Co. Business Overview Table 123. Merck & Co. Antihelminthics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Merck & Co. Antihelminthics Product Portfolio Table 125. Merck & Co. Recent Development Table 126. Mentis Pharma Company Information Table 127. Mentis Pharma Business Overview Table 128. Mentis Pharma Antihelminthics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Mentis Pharma Antihelminthics Product Portfolio Table 130. Mentis Pharma Recent Development Table 131. Astellas Pharma Company Information Table 132. Astellas Pharma Business Overview Table 133. Astellas Pharma Antihelminthics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Astellas Pharma Antihelminthics Product Portfolio Table 135. Astellas Pharma Recent Development Table 136. ALLERGAN Company Information Table 137. ALLERGAN Business Overview Table 138. ALLERGAN Antihelminthics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. ALLERGAN Antihelminthics Product Portfolio Table 140. ALLERGAN Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Antihelminthics Distributors List Table 144. Antihelminthics Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Antihelminthics Product Image Figure 2. Global Antihelminthics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antihelminthics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Antihelminthics Sales (2021-2032) & (K Units) Figure 5. Global Antihelminthics Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Antihelminthics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Salicylanilides Image Figure 10. Benzimidazoles Image Figure 11. Praziquantel Image Figure 12. Abamectin Image Figure 13. Other Image Figure 14. Global Antihelminthics Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Antihelminthics Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Antihelminthics Sales Volume Share by Type (2021-2032) Figure 17. Global Antihelminthics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Antihelminthics Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Antihelminthics Sales Value Share by Type (2021-2032) Figure 20. Ascariasis Image Figure 21. Giardiasis Image Figure 22. Fasciolasis Image Figure 23. Filariasis Image Figure 24. Angiostrongylosis Image Figure 25. Schistosomiasis Image Figure 26. Other Image Figure 27. Global Antihelminthics Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Antihelminthics Sales Volume Share 2021 VS 2025 VS 2032 Figure 29. Global Antihelminthics Sales Volume Share by Application (2021-2032) Figure 30. Global Antihelminthics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Antihelminthics Sales Value Share 2021 VS 2025 VS 2032 Figure 32. Global Antihelminthics Sales Value Share by Application (2021-2032) Figure 33. Global Antihelminthics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 34. Global Antihelminthics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 35. Global Antihelminthics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 36. Global Antihelminthics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 37. North America Antihelminthics Sales Value (2021-2032) & (US$ Million) Figure 38. North America Antihelminthics Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Europe Antihelminthics Sales Value (2021-2032) & (US$ Million) Figure 40. Europe Antihelminthics Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Asia-Pacific Antihelminthics Sales Value (2021-2032) & (US$ Million) Figure 42. Asia-Pacific Antihelminthics Sales Value Share by Country (%), 2025 VS 2032 Figure 43. South America Antihelminthics Sales Value (2021-2032) & (US$ Million) Figure 44. South America Antihelminthics Sales Value Share by Country (%), 2025 VS 2032 Figure 45. Middle East & Africa Antihelminthics Sales Value (2021-2032) & (US$ Million) Figure 46. Middle East & Africa Antihelminthics Sales Value Share by Country (%), 2025 VS 2032 Figure 47. USA Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. USA Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. USA Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Canada Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Canada Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Canada Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Mexico Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Mexico Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Mexico Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Germany Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Germany Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Germany Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. France Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. France Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. France Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. U.K. Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. U.K. Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. U.K. Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Italy Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Italy Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Italy Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Spain Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Spain Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Spain Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Russia Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Russia Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Russia Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Netherlands Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Netherlands Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Netherlands Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Nordic Countries Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Nordic Countries Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Nordic Countries Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. China Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. China Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. China Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Japan Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Japan Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Japan Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. South Korea Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. South Korea Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. South Korea Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. India Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. India Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. India Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Australia Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Australia Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Australia Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Southeast Asia Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Southeast Asia Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Southeast Asia Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Brazil Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Brazil Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Brazil Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Argentina Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Argentina Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Argentina Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Chile Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Chile Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Chile Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Colombia Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Colombia Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Colombia Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Peru Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Peru Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Peru Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Saudi Arabia Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Saudi Arabia Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Israel Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Israel Arabia Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Israel Arabia Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. UAE Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. UAE Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. UAE Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Turkey Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Turkey Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Turkey Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Iran Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Iran Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Iran Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Egypt Antihelminthics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 129. Egypt Antihelminthics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 130. Egypt Antihelminthics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 131. Antihelminthics Value Chain Figure 132. Manufacturing Cost Structure Figure 133. Antihelminthics Sales Mode & Process Figure 134. Direct Comparison with Distribution Share Figure 135. Distributors Profiles Figure 136. Years Considered Figure 137. Research Process Figure 138. Key Executives Interviewed

Scope & coverage.

Types
  • Salicylanilides
  • Benzimidazoles
  • Praziquantel
  • Abamectin
  • Other
Applications
  • Ascariasis
  • Giardiasis
  • Fasciolasis
  • Filariasis
  • Angiostrongylosis
  • Schistosomiasis
  • Other
Companies covered
  • Abbott
  • Sanofi
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • ZEISS International
  • Merck & Co.
  • Mentis Pharma
  • Astellas Pharma
  • ALLERGAN

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antihelminthics Sales Value (2021-2032)
  4. 1.2.2 Global Antihelminthics Sales Volume (2021-2032)
  5. 1.2.3 Global Antihelminthics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Antihelminthics Market Dynamics
  1. 2.1 Antihelminthics Industry Trends
  2. 2.2 Antihelminthics Industry Drivers
  3. 2.3 Antihelminthics Industry Opportunities and Challenges
  4. 2.4 Antihelminthics Industry Restraints
3 Antihelminthics Market by Company
  1. 3.1 Global Antihelminthics Company Revenue Ranking in 2025
  2. 3.2 Global Antihelminthics Revenue by Company (2021-2026)
  3. 3.3 Global Antihelminthics Sales Volume by Company (2021-2026)
  4. 3.4 Global Antihelminthics Average Price by Company (2021-2026)
  5. 3.5 Global Antihelminthics Company Ranking (2024-2026)
  6. 3.6 Global Antihelminthics Company Manufacturing Base and Headquarters
  7. 3.7 Global Antihelminthics Company Product Type and Application
  8. 3.8 Global Antihelminthics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Antihelminthics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Antihelminthics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Antihelminthics Market by Type
  1. 4.1 Antihelminthics Type Introduction
  2. 4.1.1 Salicylanilides
  3. 4.1.2 Benzimidazoles
  4. 4.1.3 Praziquantel
  5. 4.1.4 Abamectin
  6. 4.1.5 Other
  7. 4.2 Global Antihelminthics Sales Volume by Type
  8. 4.2.1 Global Antihelminthics Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Antihelminthics Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Antihelminthics Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Antihelminthics Sales Value by Type
  12. 4.3.1 Global Antihelminthics Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Antihelminthics Sales Value by Type (2021-2032)
  14. 4.3.3 Global Antihelminthics Sales Value Share by Type (2021-2032)
5 Antihelminthics Market by Application
  1. 5.1 Antihelminthics Application Introduction
  2. 5.1.1 Ascariasis
  3. 5.1.2 Giardiasis
  4. 5.1.3 Fasciolasis
  5. 5.1.4 Filariasis
  6. 5.1.5 Angiostrongylosis
  7. 5.1.6 Schistosomiasis
  8. 5.1.7 Other
  9. 5.2 Global Antihelminthics Sales Volume by Application
  10. 5.2.1 Global Antihelminthics Sales Volume by Application (2021 VS 2025 VS 2032)
  11. 5.2.2 Global Antihelminthics Sales Volume by Application (2021-2032)
  12. 5.2.3 Global Antihelminthics Sales Volume Share by Application (2021-2032)
  13. 5.3 Global Antihelminthics Sales Value by Application
  14. 5.3.1 Global Antihelminthics Sales Value by Application (2021 VS 2025 VS 2032)
  15. 5.3.2 Global Antihelminthics Sales Value by Application (2021-2032)
  16. 5.3.3 Global Antihelminthics Sales Value Share by Application (2021-2032)
6 Antihelminthics Regional Sales and Value Analysis
  1. 6.1 Global Antihelminthics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antihelminthics Sales by Region (2021-2032)
  3. 6.2.1 Global Antihelminthics Sales by Region: 2021-2026
  4. 6.2.2 Global Antihelminthics Sales by Region (2027-2032)
  5. 6.3 Global Antihelminthics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Antihelminthics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Antihelminthics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Antihelminthics Sales Value by Region (2027-2032)
  9. 6.5 Global Antihelminthics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Antihelminthics Sales Value (2021-2032)
  12. 6.6.2 North America Antihelminthics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Antihelminthics Sales Value (2021-2032)
  15. 6.7.2 Europe Antihelminthics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Antihelminthics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Antihelminthics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Antihelminthics Sales Value (2021-2032)
  21. 6.9.2 South America Antihelminthics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Antihelminthics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Antihelminthics Sales Value Share by Country, 2025 VS 2032
7 Antihelminthics Country-level Sales and Value Analysis
  1. 7.1 Global Antihelminthics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antihelminthics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Antihelminthics Sales by Country (2021-2032)
  4. 7.3.1 Global Antihelminthics Sales by Country (2021-2026)
  5. 7.3.2 Global Antihelminthics Sales by Country (2027-2032)
  6. 7.4 Global Antihelminthics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Antihelminthics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Antihelminthics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Antihelminthics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Antihelminthics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Antihelminthics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Antihelminthics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Antihelminthics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Antihelminthics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Antihelminthics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Antihelminthics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Antihelminthics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Antihelminthics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Antihelminthics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Antihelminthics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Antihelminthics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Antihelminthics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Antihelminthics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Antihelminthics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Antihelminthics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Antihelminthics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Antihelminthics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Antihelminthics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Antihelminthics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Antihelminthics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Antihelminthics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Antihelminthics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Antihelminthics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Antihelminthics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Antihelminthics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Antihelminthics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Antihelminthics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Antihelminthics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Antihelminthics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Antihelminthics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Antihelminthics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Antihelminthics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Antihelminthics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Antihelminthics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Antihelminthics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Antihelminthics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Antihelminthics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Antihelminthics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Antihelminthics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Antihelminthics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Antihelminthics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Antihelminthics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Antihelminthics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Antihelminthics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Antihelminthics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Antihelminthics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Antihelminthics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Antihelminthics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Antihelminthics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Antihelminthics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Antihelminthics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Antihelminthics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Antihelminthics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Antihelminthics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Antihelminthics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Antihelminthics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Antihelminthics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Antihelminthics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Antihelminthics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Antihelminthics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Antihelminthics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Antihelminthics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Antihelminthics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Antihelminthics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Antihelminthics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Antihelminthics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Antihelminthics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Antihelminthics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Antihelminthics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Antihelminthics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Antihelminthics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Antihelminthics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Antihelminthics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Antihelminthics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Antihelminthics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Antihelminthics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Antihelminthics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Antihelminthics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Antihelminthics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Antihelminthics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Antihelminthics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Antihelminthics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Antihelminthics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Antihelminthics Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Antihelminthics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Antihelminthics Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Antihelminthics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Antihelminthics Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson Antihelminthics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson Antihelminthics Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Antihelminthics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Antihelminthics Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Antihelminthics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Antihelminthics Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 GlaxoSmithKline
  38. 8.7.1 GlaxoSmithKline Company Information
  39. 8.7.2 GlaxoSmithKline Business Overview
  40. 8.7.3 GlaxoSmithKline Antihelminthics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Antihelminthics Product Portfolio
  42. 8.7.5 GlaxoSmithKline Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Antihelminthics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Antihelminthics Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 AstraZeneca
  50. 8.9.1 AstraZeneca Company Information
  51. 8.9.2 AstraZeneca Business Overview
  52. 8.9.3 AstraZeneca Antihelminthics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 AstraZeneca Antihelminthics Product Portfolio
  54. 8.9.5 AstraZeneca Recent Developments
  55. 8.10 ZEISS International
  56. 8.10.1 ZEISS International Company Information
  57. 8.10.2 ZEISS International Business Overview
  58. 8.10.3 ZEISS International Antihelminthics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 ZEISS International Antihelminthics Product Portfolio
  60. 8.10.5 ZEISS International Recent Developments
  61. 8.11 Merck & Co.
  62. 8.11.1 Merck & Co. Company Information
  63. 8.11.2 Merck & Co. Business Overview
  64. 8.11.3 Merck & Co. Antihelminthics Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Merck & Co. Antihelminthics Product Portfolio
  66. 8.11.5 Merck & Co. Recent Developments
  67. 8.12 Mentis Pharma
  68. 8.12.1 Mentis Pharma Company Information
  69. 8.12.2 Mentis Pharma Business Overview
  70. 8.12.3 Mentis Pharma Antihelminthics Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Mentis Pharma Antihelminthics Product Portfolio
  72. 8.12.5 Mentis Pharma Recent Developments
  73. 8.13 Astellas Pharma
  74. 8.13.1 Astellas Pharma Company Information
  75. 8.13.2 Astellas Pharma Business Overview
  76. 8.13.3 Astellas Pharma Antihelminthics Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Astellas Pharma Antihelminthics Product Portfolio
  78. 8.13.5 Astellas Pharma Recent Developments
  79. 8.14 ALLERGAN
  80. 8.14.1 ALLERGAN Company Information
  81. 8.14.2 ALLERGAN Business Overview
  82. 8.14.3 ALLERGAN Antihelminthics Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 ALLERGAN Antihelminthics Product Portfolio
  84. 8.14.5 ALLERGAN Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antihelminthics Value Chain Analysis
  2. 9.1.1 Antihelminthics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antihelminthics Sales Mode & Process
  6. 9.2 Antihelminthics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antihelminthics Distributors
  9. 9.2.3 Antihelminthics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst